Incretin Based Therapies
Multiple pharmacotherapeutic agents are now used in diabetology
practice. The sheer scale of the permutations and combinations sometimes
leaves practitioners confused as to their appropriate use. The major
recent advance in diabetic drug therapy has been the development of
incretin based therapies. These agents of varying chemical structures
have changed our approach to diabetes care, bringing with them an
enhanced understanding of the pathophysiology and natural history of the
disease. However, they also bring with them a challenge for the
diabetes care professional. Confronted with a wide choice of “newer”
drugs, the diabetes care provider feels the need for more information to
write a rational prescription.
This book fulfills this need. An easily readable and comprehensible lay
out helps make complicated concepts look simple. Classification of
incretin based therapy into different groups, each discussed separately,
gives the reader clarity. For each group, an overview chapter is
followed by a focused discussion of various aspects of clinical
pharmacology. While a section on the history and developments of
incretin based therapy puts this novel class of drugs in perspective,
futuristic chapters on nondiabetic usage and combination therapy give a
glimpse of their untapped potential.
The Shipping charges include packing, shipping, forwarding and our agency charges.
The shipping charges given here are for national destinations.
